Takashi Asada
Research Subjects
Research Interests
Takashi Asada has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
- Seigo Nakano
Fifth Department of Internal Medicine, School of Medicine, Fukuoka University, Japan
4 shared publications - Takashi Ohnishi
Department of Radiology, National Center Hospital of Mental, Nervous and Muscular Disorders, National Center of Neurology and Psychiatry, 4-1-1 Ogawa Higashi, Kodaira City, Tokyo 187-8551, Japan
4 shared publications - Etsuko Imabayashi
Integrative Brain Imaging Center, National Center of Neurology and Psychiatry
3 shared publications - Hiroshi Matsuda
Integrative Brain Imaging Center, National Center of Neurology and Psychiatry
3 shared publications Masatake Uno
3 shared publicationsShigeki Sakamoto
3 shared publications
Latest Publications
- 31 December 2010
- Published by Elsevier in Neuroscience Research
- Vol. 68, e305
Generation of disease-specific induced pluripotent stem cells from Alzheimer's disease patients
- 31 December 2010
- Published by Elsevier in Neuroscience Research
- Vol. 68, e305
Generation of disease-specific induced pluripotent stem cells from Alzheimer's disease patients
- 1 September 2004
- Vol. 45 (9) , 1450-7
Superiority of 3-dimensional stereotactic surface projection analysis over visual inspection in discrimination of patients with very early Alzheimer's disease from controls using brain perfusion SPECT.
In Alzheimer's disease (AD), regional cerebral blood flow (rCBF) in the posterior cingulate gyri and precunei has been reported to decrease even at a very early stage. It may be helpful to use statistical image analysis to distinguish slight decreases in rCBF in this area. We compared a 3-dimensional stereotactic surface projection (3D-SSP) technique with visual inspection in the discrimination of patients with very early AD from age-matched controls using brain perfusion SPECT. SPECT was obtained in 38 patients with probable AD at a very early stage and after a mean interval of 15 mo and in 76 age-matched healthy volunteers. We randomly divided these subjects into 2 groups. The first group was used to identify the areas with significant decreases of rCBF in patients compared with healthy control subjects based on the voxel-based analysis using 3D-SSP. The second group was used to compare the discrimination ability between patients and control subjects by 3D-SSP with that by visual inspection. In the second group, a Z-score map for a SPECT image of a subject was obtained by comparison with mean and SD SPECT images of control subjects for each voxel after anatomic standardization and voxel normalization to reference regions. Receiver operating characteristic (ROC) curves for a Z-score discriminating patients with AD from control subjects were analyzed in areas with significant decreases of rCBF identified in the first group. For visual inspection, 6 physicians graded the rCBF decrease on SPECT images for ROC curves. They inspected the images twice at an interval of >2 wk, and intra- and interobserver reliabilities were determined. Visual inspection showed fair-to-excellent intra- and interobserver reliabilities. The 3D-SSP demonstrated an accuracy of 86.2% for discriminating patients with AD from control subjects when analyzing the posterior cingulate gyri and precunei with global mean normalization. In contrast, visual inspection did not show an accuracy of >74.0% for this discrimination. The ability of 3D-SSP to discriminate patients with very early AD from control subjects is superior to that of visual inspection. It is clinically useful and reliable to adopt the use of 3D-SSP as an adjunct to visual interpretation.
- 1 September 2004
- Vol. 45 (9) , 1450-7
Superiority of 3-dimensional stereotactic surface projection analysis over visual inspection in discrimination of patients with very early Alzheimer's disease from controls using brain perfusion SPECT.
In Alzheimer's disease (AD), regional cerebral blood flow (rCBF) in the posterior cingulate gyri and precunei has been reported to decrease even at a very early stage. It may be helpful to use statistical image analysis to distinguish slight decreases in rCBF in this area. We compared a 3-dimensional stereotactic surface projection (3D-SSP) technique with visual inspection in the discrimination of patients with very early AD from age-matched controls using brain perfusion SPECT. SPECT was obtained in 38 patients with probable AD at a very early stage and after a mean interval of 15 mo and in 76 age-matched healthy volunteers. We randomly divided these subjects into 2 groups. The first group was used to identify the areas with significant decreases of rCBF in patients compared with healthy control subjects based on the voxel-based analysis using 3D-SSP. The second group was used to compare the discrimination ability between patients and control subjects by 3D-SSP with that by visual inspection. In the second group, a Z-score map for a SPECT image of a subject was obtained by comparison with mean and SD SPECT images of control subjects for each voxel after anatomic standardization and voxel normalization to reference regions. Receiver operating characteristic (ROC) curves for a Z-score discriminating patients with AD from control subjects were analyzed in areas with significant decreases of rCBF identified in the first group. For visual inspection, 6 physicians graded the rCBF decrease on SPECT images for ROC curves. They inspected the images twice at an interval of >2 wk, and intra- and interobserver reliabilities were determined. Visual inspection showed fair-to-excellent intra- and interobserver reliabilities. The 3D-SSP demonstrated an accuracy of 86.2% for discriminating patients with AD from control subjects when analyzing the posterior cingulate gyri and precunei with global mean normalization. In contrast, visual inspection did not show an accuracy of >74.0% for this discrimination. The ability of 3D-SSP to discriminate patients with very early AD from control subjects is superior to that of visual inspection. It is clinically useful and reliable to adopt the use of 3D-SSP as an adjunct to visual interpretation.
- 1 August 2003
- Vol. 44 (8) , 1243-52
Correction for partial-volume effects on brain perfusion SPECT in healthy men.
The limited spatial resolution of SPECT scanners does not allow an exact measurement of the local radiotracer concentration in brain tissue because partial-volume effects (PVEs) underestimate concentration in small structures of the brain. The aim of this study was to determine which brain structures show greater influence of PVEs in SPECT studies on healthy volunteers and to investigate aging effects on SPECT after the PVE correction. Brain perfusion SPECT using (99m)Tc-ethylcysteinate dimer was performed in 52 healthy men, 18-86 y old. The regional cerebral blood flow (rCBF) was noninvasively measured using graphical analysis. SPECT images were corrected for PVEs using gray-matter volume, which was segmented from coregistered MR images and convoluted with spatial resolution of SPECT scanners. Absolute rCBF data were measured using a 3-dimensional (3D) stereotactic template for regions of interest on anatomically standardized SPECT. We examined correlation of advancing age with rCBF before and after the PVE correction. To validate the correction method for PVEs, a Hoffman 3D brain phantom experiment was also performed. The PVE correction remarkably reduced the coefficient of variation for SPECT counts in the whole phantom. The PVE correction made the rCBF distribution more homogeneous throughout the brain with less intersubject variation than the original distribution. There were significant negative correlations between age and adjusted rCBF in the bilateral perisylvian and medial frontal areas. These correlations remained significant after the PVE correction. Instead of a positive correlation in the medial temporal structures between age and adjusted rCBF before the PVE correction, the sensorimotor and parietal areas mainly showed positive correlations after the correction. SPECT data reflect both brain volume loss and functional changes. Use of the PVE correction in brain perfusion SPECT provides a more accurate determination of rCBF even in healthy volunteers.
- 1 August 2003
- Vol. 44 (8) , 1243-52
Correction for partial-volume effects on brain perfusion SPECT in healthy men.
The limited spatial resolution of SPECT scanners does not allow an exact measurement of the local radiotracer concentration in brain tissue because partial-volume effects (PVEs) underestimate concentration in small structures of the brain. The aim of this study was to determine which brain structures show greater influence of PVEs in SPECT studies on healthy volunteers and to investigate aging effects on SPECT after the PVE correction. Brain perfusion SPECT using (99m)Tc-ethylcysteinate dimer was performed in 52 healthy men, 18-86 y old. The regional cerebral blood flow (rCBF) was noninvasively measured using graphical analysis. SPECT images were corrected for PVEs using gray-matter volume, which was segmented from coregistered MR images and convoluted with spatial resolution of SPECT scanners. Absolute rCBF data were measured using a 3-dimensional (3D) stereotactic template for regions of interest on anatomically standardized SPECT. We examined correlation of advancing age with rCBF before and after the PVE correction. To validate the correction method for PVEs, a Hoffman 3D brain phantom experiment was also performed. The PVE correction remarkably reduced the coefficient of variation for SPECT counts in the whole phantom. The PVE correction made the rCBF distribution more homogeneous throughout the brain with less intersubject variation than the original distribution. There were significant negative correlations between age and adjusted rCBF in the bilateral perisylvian and medial frontal areas. These correlations remained significant after the PVE correction. Instead of a positive correlation in the medial temporal structures between age and adjusted rCBF before the PVE correction, the sensorimotor and parietal areas mainly showed positive correlations after the correction. SPECT data reflect both brain volume loss and functional changes. Use of the PVE correction in brain perfusion SPECT provides a more accurate determination of rCBF even in healthy volunteers.
- 1 April 2003
- Published by Wiley in Journal of Neuroimaging
- Vol. 13 (2) , 113-123
Apolipoprotein E Genotype and Early Alzheimer’s Disease: A Longitudinal SPECT Study
To determine the association of the apolipoprotein E (APOE) genotype and longitudinal changes of regional cerebral blood flow (rCBF) in Alzheimer's disease (AD). Previous reports have yielded conflicting results concerning this association. A retrospective cohort study was performed. rCBF was noninvasively measured using 99mTc-ethyl cysteinate dimer single-photon emission computed tomography in 23 patients with probable AD at the very early stage and at a mean interval of 24 months, as well as in 55 age-matched healthy volunteers. Patients were classified into 2 groups according to the presence of the epsilon 4 allele: 11 epsilon 4 carriers and 12 noncarriers. Correction for partial volume effects (PVEs) was performed in all patients using gray matter volume measured by magnetic resonance imaging. Statistical parametric mapping was used for the analysis of absolute rCBF data and the adjusted rCBF images of relative flow distribution. In the baseline study, both carriers and noncarriers showed significant decreases of absolute and adjusted rCBF in the psoterior cingulate gyri and precunei. After PVE correction, carriers showed a greater spread of areas with significant rCBF reduction from the parietotemporal to the frontal area than noncarriers during the follow-up period compared to healthy volunteers. Moreover, carriers showed a significant decline of absolute rCBF in the frontal cortex from the baseline to the follow-up study. The authors' study suggests that the APOE epsilon 4 allele is associated with the faster progression of AD, and PVE correction may be necessary for accurate assessments of SPECT studies of AD.
- 1 April 2003
- Published by Wiley in Journal of Neuroimaging
- Vol. 13 (2) , 113-123
Apolipoprotein E Genotype and Early Alzheimer’s Disease: A Longitudinal SPECT Study
To determine the association of the apolipoprotein E (APOE) genotype and longitudinal changes of regional cerebral blood flow (rCBF) in Alzheimer's disease (AD). Previous reports have yielded conflicting results concerning this association. A retrospective cohort study was performed. rCBF was noninvasively measured using 99mTc-ethyl cysteinate dimer single-photon emission computed tomography in 23 patients with probable AD at the very early stage and at a mean interval of 24 months, as well as in 55 age-matched healthy volunteers. Patients were classified into 2 groups according to the presence of the epsilon 4 allele: 11 epsilon 4 carriers and 12 noncarriers. Correction for partial volume effects (PVEs) was performed in all patients using gray matter volume measured by magnetic resonance imaging. Statistical parametric mapping was used for the analysis of absolute rCBF data and the adjusted rCBF images of relative flow distribution. In the baseline study, both carriers and noncarriers showed significant decreases of absolute and adjusted rCBF in the psoterior cingulate gyri and precunei. After PVE correction, carriers showed a greater spread of areas with significant rCBF reduction from the parietotemporal to the frontal area than noncarriers during the follow-up period compared to healthy volunteers. Moreover, carriers showed a significant decline of absolute rCBF in the frontal cortex from the baseline to the follow-up study. The authors' study suggests that the APOE epsilon 4 allele is associated with the faster progression of AD, and PVE correction may be necessary for accurate assessments of SPECT studies of AD.
- 1 July 2002
- Vol. 49 (7) , 620-30
[A 7-year follow-up study of cases with dementia to identify predictors of mortality].
To identify factors associated with mortality in cases with Alzheimer's disease (AD) and vascular dementia (VD), we conducted a seven-year follow-up study. Subjects were recruited through three agents in Yamanashi prefecture. A total of 145 patients (56 men, 89 women, age at baseline 77 +/- 7.9, 80 +/- 8.5 years respectively) with AD and VD participated in the follow-up study. We analyzed the relationship between demographic or clinical variables and their survival using a Cox regression model. The analysis revealed that increased age, male gender, the degree of global function and past history of a fall/fracture were associated with a decreased survival rate. The rate was worse for patients with VD than for those with AD. After adjusting for age and gender, the mortality risk ratio was 1.7 (95% confidence interval 1.1-2.6) for the presence of a fall/fracture. The same analysis confined to 64 subjects for whom ApoE genotyping data were available replicated the results; a fall/fracture was a predictor of a worse survival rate. In addition, those with ApoE4 tended to have better survival rate than those without (P < 0.1). Those who are engaged in care for AD patients should appreciate the importance of a fall/fracture as a predictor of survival.
- 1 July 2002
- Vol. 49 (7) , 620-30
[A 7-year follow-up study of cases with dementia to identify predictors of mortality].
To identify factors associated with mortality in cases with Alzheimer's disease (AD) and vascular dementia (VD), we conducted a seven-year follow-up study. Subjects were recruited through three agents in Yamanashi prefecture. A total of 145 patients (56 men, 89 women, age at baseline 77 +/- 7.9, 80 +/- 8.5 years respectively) with AD and VD participated in the follow-up study. We analyzed the relationship between demographic or clinical variables and their survival using a Cox regression model. The analysis revealed that increased age, male gender, the degree of global function and past history of a fall/fracture were associated with a decreased survival rate. The rate was worse for patients with VD than for those with AD. After adjusting for age and gender, the mortality risk ratio was 1.7 (95% confidence interval 1.1-2.6) for the presence of a fall/fracture. The same analysis confined to 64 subjects for whom ApoE genotyping data were available replicated the results; a fall/fracture was a predictor of a worse survival rate. In addition, those with ApoE4 tended to have better survival rate than those without (P < 0.1). Those who are engaged in care for AD patients should appreciate the importance of a fall/fracture as a predictor of survival.
- 1 March 2002
- Vol. 43 (3) , 304-11
Longitudinal evaluation of both morphologic and functional changes in the same individuals with Alzheimer's disease.
Morphologic and functional imaging studies have not always given concordant results about brain areas showing atrophic changes and reduced flow or metabolism in Alzheimer's disease (AD). The aim of this study was to determine the initial abnormality and the longitudinal changes in both morphologic and functional measurements for the same individuals with AD. We investigated 15 patients with mild AD and 25 age-matched healthy volunteers. The AD patients underwent both MRI and SPECT 3 times at intervals of approximately 1 y. The gray matter volume, as segmented from MRI, and the regional cerebral blood flow (rCBF), as measured by SPECT, of AD patients were compared with those of healthy volunteers using statistical parametric mapping, which is a voxel-based analysis in stereotactic space. Considerable discordance between areas of regional atrophy and areas of decreased rCBF was observed. The medial temporal areas showed a faster and more extensive reduction of gray matter volume than of rCBF. In comparison with the value at the baseline study, rCBF in the posterior cingulate gyrus and precuneus and the associative parietal cortex was extensively decreased. In contrast, the extent of significant decrease in this area continued to be much narrower for gray matter volume than for rCBF, even in the follow-up studies. Frontal areas, including the anterior cingulate gyrus and the orbitofrontal areas, showed a progressive reduction in both rCBF and gray matter volume. The reduction in rCBF was in a more posterior part of the associative temporal cortex than was the reduction in gray matter volume. These results indicate a distinct discordance between morphologic and functional changes in a longitudinal study of AD. Functional changes may be caused partly by remote effects from the morphologically involved areas with decreased connectivity and partly by a compensatory response by neuronal plasticity.
- 1 March 2002
- Vol. 43 (3) , 304-11
Longitudinal evaluation of both morphologic and functional changes in the same individuals with Alzheimer's disease.
Morphologic and functional imaging studies have not always given concordant results about brain areas showing atrophic changes and reduced flow or metabolism in Alzheimer's disease (AD). The aim of this study was to determine the initial abnormality and the longitudinal changes in both morphologic and functional measurements for the same individuals with AD. We investigated 15 patients with mild AD and 25 age-matched healthy volunteers. The AD patients underwent both MRI and SPECT 3 times at intervals of approximately 1 y. The gray matter volume, as segmented from MRI, and the regional cerebral blood flow (rCBF), as measured by SPECT, of AD patients were compared with those of healthy volunteers using statistical parametric mapping, which is a voxel-based analysis in stereotactic space. Considerable discordance between areas of regional atrophy and areas of decreased rCBF was observed. The medial temporal areas showed a faster and more extensive reduction of gray matter volume than of rCBF. In comparison with the value at the baseline study, rCBF in the posterior cingulate gyrus and precuneus and the associative parietal cortex was extensively decreased. In contrast, the extent of significant decrease in this area continued to be much narrower for gray matter volume than for rCBF, even in the follow-up studies. Frontal areas, including the anterior cingulate gyrus and the orbitofrontal areas, showed a progressive reduction in both rCBF and gray matter volume. The reduction in rCBF was in a more posterior part of the associative temporal cortex than was the reduction in gray matter volume. These results indicate a distinct discordance between morphologic and functional changes in a longitudinal study of AD. Functional changes may be caused partly by remote effects from the morphologically involved areas with decreased connectivity and partly by a compensatory response by neuronal plasticity.
- 25 December 2000
- Published by Wiley in Psychiatry and Clinical Neurosciences
- Vol. 54 (6) , 673-677
Predictors of severity of behavioral disturbance among community‐dwelling elderly individuals with Alzheimer's disease: A 6‐year follow‐up study
To clarify which baseline factors, including apolipoprotein E (ApoE) genotyping and caregiver characteristics, predict the future severity of behavioral disturbance among community-dwelling elderly with Alzheimer's disease (AD), we conducted a longitudinal study for up to 6 years. Fourteen kinds of behavioral disturbance were evaluated. Analyses using data from 62 subjects with at least three annual assessments revealed that the baseline severity of behavioral disturbance was the strongest predictor of future severity, followed by baseline stage of dementia or use of support services. However, ApoE ɛ4 had only a marginal effect at most. The behavioral disturbances examined in the present study appear to be innately determined phenomena rather than merely representing stages of AD.
- 25 December 2000
- Published by Wiley in Psychiatry and Clinical Neurosciences
- Vol. 54 (6) , 673-677
Predictors of severity of behavioral disturbance among community‐dwelling elderly individuals with Alzheimer's disease: A 6‐year follow‐up study
To clarify which baseline factors, including apolipoprotein E (ApoE) genotyping and caregiver characteristics, predict the future severity of behavioral disturbance among community-dwelling elderly with Alzheimer's disease (AD), we conducted a longitudinal study for up to 6 years. Fourteen kinds of behavioral disturbance were evaluated. Analyses using data from 62 subjects with at least three annual assessments revealed that the baseline severity of behavioral disturbance was the strongest predictor of future severity, followed by baseline stage of dementia or use of support services. However, ApoE ɛ4 had only a marginal effect at most. The behavioral disturbances examined in the present study appear to be innately determined phenomena rather than merely representing stages of AD.
- Open Access
- 25 December 2000
- Published by Wiley in Psychiatry and Clinical Neurosciences
- Vol. 54 (6) , 691-694
Quantitative single photon emission tomography analysis for the diagnosis of transient global amnesia: Adaptation of statistical parametric mapping
- 25 December 2000
- Published by Wiley in Psychiatry and Clinical Neurosciences
- Vol. 54 (6) , 691-694
Open AccessQuantitative single photon emission tomography analysis for the diagnosis of transient global amnesia: Adaptation of statistical parametric mapping
- Open Access
- 1 August 2000
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 23 (5) , 1-6
Associations between retrospectively recalled napping behavior and later development of Alzheimer's disease: association with APOE genotypes.
To evaluate putative risk factors for Alzheimer's disease (AD), we conducted a case-control study with exposure assessment performed after disease onset. In this study, we evaluated the effect of recalled habitual napping according to its duration and examined whether APOE genotype modifies the effect. The subjects were 337 patients (144 men, 193 women, age at onset and the time of study (years): 69+/-10, 73+/-9) with a diagnosis of probable AD based on the NINCDS-ADRDA criteria. Two hundred and sixty spouses of the subjects (94 men, 166 women, age at the time of study: 69+/-9) served as controls. We asked retrospectively about habitual (3 or more days per week) napping and its duration observed between 5 and 10 years before the onset of AD for cases, and between 5 and 10 years before the time of the study for controls. The analysis revealed that limited napping for up to 60 min had an apparently protective effect against the development of AD, especially for carriers of the APOEepsilon 4 allele. By contrast, napping for more than 60 min increased the risk of AD morbidity among the carriers of the allele. Habitual napping may modulate or disturb the physiological functions of sleep and circadian time-keeping according to its duration, and this might be associated with some mechanism that leads to the development of AD.
- 1 August 2000
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 23 (5) , 1-6
Open AccessAssociations between retrospectively recalled napping behavior and later development of Alzheimer's disease: association with APOE genotypes.
To evaluate putative risk factors for Alzheimer's disease (AD), we conducted a case-control study with exposure assessment performed after disease onset. In this study, we evaluated the effect of recalled habitual napping according to its duration and examined whether APOE genotype modifies the effect. The subjects were 337 patients (144 men, 193 women, age at onset and the time of study (years): 69+/-10, 73+/-9) with a diagnosis of probable AD based on the NINCDS-ADRDA criteria. Two hundred and sixty spouses of the subjects (94 men, 166 women, age at the time of study: 69+/-9) served as controls. We asked retrospectively about habitual (3 or more days per week) napping and its duration observed between 5 and 10 years before the onset of AD for cases, and between 5 and 10 years before the time of the study for controls. The analysis revealed that limited napping for up to 60 min had an apparently protective effect against the development of AD, especially for carriers of the APOEepsilon 4 allele. By contrast, napping for more than 60 min increased the risk of AD morbidity among the carriers of the allele. Habitual napping may modulate or disturb the physiological functions of sleep and circadian time-keeping according to its duration, and this might be associated with some mechanism that leads to the development of AD.